James Hollingshead - Net Worth and Insider Trading
James Hollingshead Net Worth
The estimated net worth of James Hollingshead is at least $22 Million dollars as of 2024-04-26. James Hollingshead is the President, Sleep Business of ResMed Inc and owns about 76,721 shares of ResMed Inc (RMD) stock worth over $17 Million. James Hollingshead is also the President and CEO of Insulet Corp and owns about 34,177 shares of Insulet Corp (PODD) stock worth over $6 Million. Details can be seen in James Hollingshead's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James Hollingshead has not made any transactions after 2023-08-28 and currently still holds the listed stock(s).
Transaction Summary of James Hollingshead
James Hollingshead Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Hollingshead owns 2 companies in total, including ResMed Inc (RMD) , and Insulet Corp (PODD) .
Click here to see the complete history of James Hollingshead’s form 4 insider trades.
Insider Ownership Summary of James Hollingshead
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RMD | ResMed Inc | 2021-12-01 | President & Sleep Business |
| PODD | Insulet Corp | 2023-08-28 | director |
James Hollingshead Latest Holdings Summary
James Hollingshead currently owns a total of 2 stocks. Among these stocks, James Hollingshead owns 76,721 shares of ResMed Inc (RMD) as of December 1, 2021, with a value of $17 Million and a weighting of 74.65%. James Hollingshead also owns 34,177 shares of Insulet Corp (PODD) as of August 28, 2023, with a value of $6 Million and a weighting of 25.35%.
Latest Holdings of James Hollingshead
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RMD | ResMed Inc | 2021-12-01 | 76,721 | 218.06 | 16,729,781 |
| PODD | Insulet Corp | 2023-08-28 | 34,177 | 166.19 | 5,679,876 |
Holding Weightings of James Hollingshead
James Hollingshead Form 4 Trading Tracker
According to the SEC Form 4 filings, James Hollingshead has made a total of 29 transactions in ResMed Inc (RMD) over the past 5 years, including 0 buys and 29 sells. The most-recent trade in ResMed Inc is the sale of 2,400 shares on December 1, 2021, which brought James Hollingshead around $616,416.
According to the SEC Form 4 filings, James Hollingshead has made a total of 1 transactions in Insulet Corp (PODD) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Insulet Corp is the acquisition of 5,550 shares on August 28, 2023, which cost James Hollingshead around $1 Million.
Insider Trading History of James Hollingshead
- 1
James Hollingshead Trading Performance
GuruFocus tracks the stock performance after each of James Hollingshead's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James Hollingshead is 2.49%. GuruFocus also compares James Hollingshead's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Hollingshead within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James Hollingshead's insider trading performs compared to the benchmark.
Performance of James Hollingshead
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -9.57 | 2.49 | -9.72 | |||
| Relative Return to S&P 500(%) | -6.56 | -0.25 | -24.08 |
James Hollingshead Ownership Network
Ownership Network List of James Hollingshead
Ownership Network Relation of James Hollingshead
James Hollingshead Owned Company Details
What does ResMed Inc do?
Who are the key executives at ResMed Inc?
James Hollingshead is the President & Sleep Business of ResMed Inc. Other key executives at ResMed Inc include Global General Counsel Michael J Rider , Chief Financial Officer Brett Sandercock , and Chief Executive Officer Michael J. Farrell .
ResMed Inc (RMD) Insider Trades Summary
Over the past 18 months, James Hollingshead made no insider transaction in ResMed Inc (RMD). Other recent insider transactions involving ResMed Inc (RMD) include a net sale of 72,983 shares made by Michael J. Farrell , a net sale of 23,280 shares made by Robert Andrew Douglas , and a net sale of 37,000 shares made by Brett Sandercock .
In summary, during the past 3 months, insiders sold 23,816 shares of ResMed Inc (RMD) in total and bought 0 shares, with a net sale of 23,816 shares. During the past 18 months, 183,814 shares of ResMed Inc (RMD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 183,814 shares.
ResMed Inc (RMD)'s detailed insider trading history can be found in Insider Trading Tracker table.
ResMed Inc Insider Transactions
James Hollingshead Mailing Address
Above is the net worth, insider trading, and ownership report for James Hollingshead. You might contact James Hollingshead via mailing address: C/o Resmed Inc., 9001 Spectrum Center Boulevard, San Diego Ca 92123.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
